Brainstorm Cell Therapeutics Stock Investor Sentiment

BCLI Stock  USD 1.89  0.10  5.03%   
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  

Brainstorm Cell Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at benzinga.com         
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell T...
benzinga news
over a year ago at benzinga.com         
Glancy Prongay Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ...
benzinga news
over a year ago at benzinga.com         
SHAREHOLDER ALERT Levi Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Act...
benzinga news
over a year ago at benzinga.com         
BRAINSTORM CELL ALERT Bragar Eagel Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Be...
benzinga news
over a year ago at finance.yahoo.com         
BrainStorm Issues 2023 Letter to Shareholders
Yahoo News
over a year ago at benzinga.com         
BCLI INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Brainstorm Cell Therapeutics Inc....
benzinga news
over a year ago at benzinga.com         
SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a...
benzinga news
over a year ago at benzinga.com         
BRAINSTORM ONGOING DEADLINE ALERT Faruqi Faruqi Securities Litigation Partner James Wilson Encourage...
benzinga news
over a year ago at benzinga.com         
DEADLINE ALERT for SEDG, BCLI, BCLYFBCS, and OTLK The Law Offices of Frank R. Cruz Reminds Investors...
benzinga news
over a year ago at benzinga.com         
ROSEN, THE FIRST FILING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Couns...
benzinga news
over a year ago at benzinga.com         
SHAREHOLDER ALERT Levi Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Act...
benzinga news
over a year ago at benzinga.com         
DEADLINE ALERT for DCGO, SEDG, BCLI, BCS Law Offices of Howard G. Smith Reminds Investors of Class A...
benzinga news
over a year ago at thelincolnianonline.com         
StockNews.com Initiates Coverage on Brainstorm Cell Therapeutics
news
over a year ago at benzinga.com         
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Co...
benzinga news
over a year ago at benzinga.com         
BRAINSTORM CELL ALERT Bragar Eagel Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Be...
benzinga news
Far too much social signal, news, headlines, and media speculation about Brainstorm Cell that are available to investors today. That information is available publicly through Brainstorm media outlets and privately through word of mouth or via Brainstorm internal channels. However, regardless of the origin, that massive amount of Brainstorm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainstorm Cell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainstorm Cell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainstorm Cell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainstorm Cell alpha.

Brainstorm Cell Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn Expanded Access Program at 2024 Annual NEALS Meeting
10/28/2024
2
Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3
11/12/2024
3
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
12/09/2024
4
Acquisition by Arbel Irit of 30666 shares of Brainstorm Cell subject to Rule 16b-3
12/31/2024
5
BCLI Plans Coming Together for Phase 3b Trial of NurOwn in ALS
01/06/2025
6
Brainstorm Cell Therapeutics faces Nasdaq delisting
01/15/2025

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories